In osteosarcoma (OS), IRX2 modulates the expression levels of MMP2 and VEGF in an AKT-dependent manner, and overexpression of IRX2 promotes the activation of PI3K/Akt and increases the proliferation and invasiveness of OS cell lines [55]. Here, IRX2 is linked to osteosarcoma.